Two New 3,4;9,10-seco-Cycloartane Type Triterpenoids from Illicium difengpi and Their Anti-Inflammatory Activities

Research Progress on Illicium difengpi (Illiciaceae): A Review

Illicium difengpi K.I.B. et K.I.M. is a member of the Illiciaceae family with a yet not fully explored utilization value. To provide references for the systematic understanding of I. difengpi (Illiciaceae), the morphological and structural characteristics, wild resource distribution, chemical compounds, pharmacological effects, utilization, and protective measures of this species are reviewed. We conclude that (i) I. difengpi (Illiciaceae) is an endemic and indigenous medicinal species that has been used to treat rheumatoid arthritis and traumatic injury in China; (ii) I. difengpi (Illiciaceae) can endure various abiotic stresses, especially extreme drought, and thus has scientific value for exploring adaptive mechanisms of tolerance to extreme drought and in the ecological restoration of karst rocky desertification areas; and (iii) the beautiful tree shapes of I. difengpi (Illiciaceae) give it potential ornamental value. However, the wild resources of I. difengpi (Illiciaceae) have rapidly decreased, and there is an urgent need to protect this endangered species to maintain its diversity. Protection measures include the protection of wild germplasm resources, the establishment of an I. difengpi (Illiciaceae) germplasm resource bank, and the development of large-scale ecological planting techniques. In further research, the medicinal and scientific value of I. difengpi (Illiciaceae) should be systematically explored to clarify the plant’s effective pharmaceutical value, clinical applications, mechanisms of drought adaptation, and genetic diversity.

Antibacterial and Anti-Inflammatory Potential of Polyherbal Formulation Used in Chronic Wound Healing

Objective

Polyherbal formulations Jathyadi Thailam and Jatyadi Ghritam (JT) are used in Indian traditional medicine for diabetic chronic wounds, fistula, fissure, eczema, and burn management. We aimed to investigate the antibacterial and anti-inflammatory properties of crude hexane and ethanol extracts of JT formulations.

Methods

Antibacterial activity of JT extracts was tested to estimate minimum inhibitory concentrations (MICs) against nine reference bacterial strains, including one methicillin-resistant Staphylococcus aureus (MRSA) and multidrug-resistant (MDR) Pseudomonas aeruginosa, and clinical strains of methicillin-susceptible S.aureus (MSSA), all involved in diabetic foot infection. The anti-inflammatory activity of plant extracts was evaluated in LPS-treated macrophage cells by measuring the mRNA levels and secretion of inflammatory mediators.

Results

The antibacterial activity of JT extracts was higher against Gram (+) bacteria, with the MICs varying from 1.95 to 62.5 mg/mL. Gram (−) bacteria were only susceptible to ethanol extracts of JT. Plant extracts were found to be the most active against the reference and clinical strains of MSSA, MRSA, and biofilm-forming S. epidermidis. JT extracts efficiently inhibited in a dose-dependent manner the mRNA expression and protein secretion of proinflammatory cytokines IL-6 and IL-1β, and chemokines MCP-1 and CXCL10 in LPS-challenged macrophages.

Conclusion

In the present study, we have shown that extracts of JT formulations possess potent antibacterial and anti-inflammatory properties that could be involved in chronic wound healing activity and has the potential to be used as external add-on therapy in the management of multidrug-resistant bacterial infections at the wound.